Related Experiment Video
Updated: May 1, 2026

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
Immunogenicity of Staphylococcus aureus LukM/F'-PV recombinant subunits: validation of diagnostic potential and
1Department of Food Microbiology, CSIR-Central Food Technological Research Institute, Mysore 570 020, India.
Abstract:
Leukotoxin M/F'-Panton Valentine (LukM/F'-PV), a beta pore-forming toxin secreted by Staphylococcus aureus, is a major virulence factor involved in the pathogenesis of bovine mastitis. The present study was aimed to determine immunogenicity of two recombinant subunits of LukM/F'-PV, rLukM (MW 38 kDa) and rLukF (MW 39 kDa), develop and validate an indirect enzyme linked immunosorbent assay (ELISA) using polyclonal antibodies raised in rabbits, and evaluate applicability of the assay to diagnose clinical and subclinical bovine mastitis. Additionally, in vitro assays were conducted to determine abilities of antibodies to neutralize cytotoxicity of the native leukotoxin. A total of 87 bovine milk samples (healthy, subclinical and clinical mastitis) were evaluated for the presence of toxin determinants. Receiver-operator characteristic curve for the experimental ELISA values statistically interpreted a cut-off score of >0.109 OD405, with an assay specificity of 100% and sensitivity in the range of 80-87.5%. In addition, area under curve of 0.93-0.98 revealed the test was accurate in categorizing samples from infected and non-infected bovine. The rLukF IgG-ELISA was more sensitive than rLukM IgG-ELISA. Furthermore, it was evident from MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium) dye reduction, indirect immunofluorescence and lactate dehydrogenase assays that anti-rLukM/rLukF antibodies, with high neutralizing titers, inhibited in vitro leukotoxic activity and protected bovine neutrophil membrane integrity from cytotoxicity of native leukotoxin. The findings demonstrated that antibodies produced from recombinant subunits contribute to specific and sensitive immunodiagnosis and may also have the potential to provide passive therapeutic benefit in the management of bovine mastitis.
Insights
This study developed an ELISA test to detect Staphylococcus aureus leukotoxin in bovine mastitis. The test accurately diagnosed infections and showed potential for passive therapy against the toxin.
Area of Science:
- Veterinary Immunology
- Bacterial Pathogenesis
- Diagnostic Assay Development
Background:
- Staphylococcus aureus leukotoxin (LukM/F'-PV) is a key factor in bovine mastitis.
- Developing accurate diagnostic tools and therapeutic strategies for mastitis is crucial for dairy industry health.
Purpose of the Study:
- To assess the immunogenicity of recombinant LukM and LukF subunits.
- To develop and validate an indirect ELISA for diagnosing bovine mastitis.
- To evaluate the neutralizing capacity of antibodies against LukM/F'-PV.
Main Methods:
- Produced and purified recombinant LukM and LukF proteins.
- Generated rabbit polyclonal antibodies against recombinant subunits.
- Developed and validated an indirect ELISA using these antibodies on 87 bovine milk samples.
- Conducted in vitro assays (MTT, indirect immunofluorescence, LDH) to assess antibody neutralization of leukotoxin.
Main Results:
- The developed ELISA demonstrated high accuracy (AUC 0.93-0.98), specificity (100%), and sensitivity (80-87.5%) for diagnosing bovine mastitis.
- The rLukF IgG-ELISA showed higher sensitivity than the rLukM IgG-ELISA.
- Anti-rLukM/rLukF antibodies effectively neutralized leukotoxin activity in vitro, protecting neutrophil membranes.
Conclusions:
- Recombinant subunits of LukM/F'-PV are immunogenic and suitable for developing diagnostic assays.
- The validated ELISA offers a specific and sensitive method for diagnosing bovine mastitis.
- Antibodies against recombinant subunits hold potential for passive immunotherapy in bovine mastitis management.
More Related Videos
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
09:03Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018